UAB "LV PHARMA" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2021 |
---|
1,870 |
935 |
1,261 |
-1,261 |
-631 |
0.43 |
0.00 |
-65.88 |
-67.43 |
1,239 |
0 |
437 |
802 |
2022 |
---|
9,520 |
4,760 |
142 |
142 |
71 |
0.10 |
0.00 |
2.25 |
1.49 |
1,381 |
0 |
437 |
944 |
2023 |
---|
8,670 |
4,335 |
708 |
-708 |
-354 |
0.03 |
0.00 |
-7.34 |
-8.17 |
673 |
2 |
447 |
228 |
Register and
explore Okredo data2023 |
---|
8,670 |
4,335 |
708 |
-708 |
-354 |
0.03 |
0.00 |
-7.34 |
-8.17 |
673 |
2 |
447 |
228 |
Register and
explore Okredo data2023
Turnover (€)
8,670 €-9 % *
Sales per employee (€)
4,335 €-9 % *
Profit before tax (€)
708 €399 % *
Net Profit (€)
-708 €-599 % *
Profit per employee (€)
-354 €-599 % *
Working capital requirement
0.03 -70.00 % *
Debt-to-equity ratio
0.00 - *
Total profitability (%)
-7.34 %-426.22 % *
Net profitability (%)
-8.17 %-648.32 % *
Equity (€)
673 €-51 % *
Amounts Payable And Liabilities (€)
2 €- *
Non-current Assets (€)
447 €2 % *
CurrentAssets (€)
228 €-76 % *